Hitoshi Kusaba
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
- Immunology top 10%
- Immune Cell Function and Interaction
Papers in
- Oncology 61
- Colorectal Cancer Treatments and Studies 16
- Cancer Immunotherapy and Biomarkers 12
- Cancer Treatment and Pharmacology 10
- Drug Transport and Resistance Mechanisms 8
- Cancer Cells and Metastasis 6
-
- Gastric Cancer Management and Outcomes 11
- Co-authors
- Eishi Baba (79 shared papers)Koichi Akashi (66 shared papers)Hiroshi Ariyama (63 shared papers)Michihiko Kuwano (7 shared papers)Morimasa Wada (7 shared papers)Taishi Harada (5 shared papers)Mamoru Ito (22 shared papers)Kenji Tsuchihashi (30 shared papers)
- Journals
- Medicine (10 papers)Cancer Chemotherapy and Pharmacology (8 papers)Cancer Science (6 papers)Anti-Cancer Drugs (5 papers)Japanese Journal of Clinical Oncology (5 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hitoshi Kusaba
105 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 97
- Oncology 780
- Immunology 271
- Cancer Research 165
- Molecular Biology 680
- Pulmonary and Respiratory Medicine 266
Countries citing papers authored by Hitoshi Kusaba
This map shows the geographic impact of Hitoshi Kusaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Kusaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Kusaba more than expected).
Fields of papers citing papers by Hitoshi Kusaba
This network shows the impact of papers produced by Hitoshi Kusaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Kusaba. The network helps show where Hitoshi Kusaba may publish in the future.
Co-authors
The 25 scholars most cited alongside Hitoshi Kusaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 141 | |
| 2 | 1998 | 112 | |
| 3 | 2003 | 99 | |
| 4 | 2018 | 94 | |
| 5 | 2020 | 72 | |
| 6 | 2014 | 61 | |
| 7 | 2020 | 59 | |
| 8 | 2020 | 53 | |
| 9 | 1999 | 53 | |
| 10 | 2004 | 48 | |
| 11 | 2008 | 45 | |
| 12 | 2017 | 40 | |
| 13 | 2010 | 38 | |
| 14 | 2018 | 36 | |
| 15 | 2018 | 36 | |
| 16 | 2011 | 36 | |
| 17 | 2006 | 33 | |
| 18 | 2009 | 31 | |
| 19 | 2016 | 30 | |
| 20 | 2020 | 27 |
About Hitoshi Kusaba
Hitoshi Kusaba is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine, having authored 112 papers that have together received 1.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Cancer Immunotherapy and Biomarkers (12 papers), Gastric Cancer Management and Outcomes (11 papers), Cancer Treatment and Pharmacology (10 papers), Drug Transport and Resistance Mechanisms (8 papers), Immune Cell Function and Interaction (8 papers), Neuroendocrine Tumor Research Advances (7 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Oncology (780 citations), Immunology (271 citations), Cancer Research (165 citations), Molecular Biology (680 citations) and Pulmonary and Respiratory Medicine (266 citations). Hitoshi Kusaba has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Eishi Baba, Koichi Akashi, Hiroshi Ariyama, Michihiko Kuwano, Morimasa Wada, Taishi Harada, Mamoru Ito, Kenji Tsuchihashi, Paritosh Ghosh and Shuji Arita. Their work appears in journals such as Medicine, Cancer Chemotherapy and Pharmacology, Cancer Science, Anti-Cancer Drugs and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.